EFTA00675450.pdf

From: Richard Kahn To: Jeffrey Epstein Subject: Fwd: Next Entities Date: Mon, 30 Oct 2017 19:54:32 +0000 Richard Kahn From: Neale Attenborough < Date: October 30, 2017 at 3:48:55 PM EDT To: Richard Kahn Cc: Chris Lawler Subject: Re: Next Entities Thanks for following up RIchard. , Tyler Shean >, Rachel Masory The attorney (or actually I guess he is more of a legal advisor) said he would get us a set of feedback this week, and we will respond after seeing that information. Thanks, neale On Oct 30, 2017, at 2:48 PM, Richard Kahn c > wrote: when can i expect your term sheet. it is obviosuly impossible to pin down exact amounts of liability... Please advise Thank you. Richard Kahn MARK Acenrintae Inn EFTA00675450 On Oct 21, 2017, at 9:25 AM, Neale Attenborough < > wrote: Richard can you let us know when you will connect Rachel and the company's attorneys? It is the only outstanding item to moving forward. On Oct 10, 2017, at 9:41 AM, Neale Attenborough < > wrote: We are awaiting g your introduction of Rachel to the company's attorneys so she can discuss the legal items. (Unless that already happened last week while I was out) On Oct 10, 2017, at 9:09 AM, Richard Kahn < where are we? Richard Kahn HBRK Associates Inc. 575 Lexington Avenue, 4th Floor New York, NY 10022 tel 212-971-1306 fax 646-350-0954 cell 917-414-7584 On Sep 29, 2017, at 11:32 AM, Neale Attenborough Thanks Richard. Two questions. First is the "Milan Issue" an action that has commenced already? wrote: > wrote: Second can you please put us in touch directly with the company's attorneys so our inside counsel, Rachel Masory copied above, can have a direct discussion with them about all the cases you forwarded from them? Thanks, Neale On Sep 29, 2017, at 8:41 AM, Richard Kahn < neale the last remaining issue is the antitrust in milan. should be in 2018.. wrote: EFTA00675451 Richard Kahn HBRK Associates Inc. 575 Lexington Avenue, 4th Floor New York, NY 10022 tel 212-971-1306 fax 646-350-0954 cell 917-414-7584 On Sep 21, 2017, at 8:48 AM, Neale Attenborough < > wrote: Is Gary the company's attorney? On Sep 21, 2017, at 6:18 AM, Richard Kahn < still waiting on paris and milan.. no need for you to reach out to gary.. Richard Kahn HBRK Associates Inc. 575 Lexington Avenue, 4th Floor New York, NY 10022 Tel 212-971-1306 Fax 646-350-0954 Cell 917-414-7584 On Sep 18, 2017, at 8:40 AM, Neale Attenborough < wrote: wrote: Thanks. Let me know when you have the information on Paris and Milan and then we'll send over our proposed LOI. Neale On Sep 18, 2017, at 6:55 AM, Richard Kahn < wrote: attached are known lawsuits against next. still waiting on 2 things: 1 from paris 1 from Milan thank you cid:4531682A900F7D42854 exch026 domain local [cid:DE598C32818B9540B8FF88647C634086@exch026.domain.local] [cid:7CEAF9E4134ACC4EB7C9D5BABBA89F19 ®exch026.domain. local] [cid:B8DE412DF13B2D439D95F4FA5F546DA0@exch026.domain. local] EFTA00675452 [cid:AB99F3085762CD458D12496555CF16F2@exch026.dornain.local] Richard Kahn HBRK Associates Inc. 575 Lexington Avenue, 4th Floor New York, NY 10022 tel 212-971-1306 fax 646-350-0954 cell 917-414-7584 On Sep 7, 2017, at 10:11 AM, Neale Attenborough kmailto >> wrote: Richard, Attached is the entity org chart for our Next Holdings. In the transaction we are contemplating, we will be selling Claxon Inc., NEXT Management Acquisition Limited, and NXT Company Limited. To be clear, at the end of the transaction we would no longer own any interests in Next. As soon as we receive your list of known actions against the company we will get you a proposed term sheet. Regards, Neale Disclaimer: This message contains information that may be confidential and/or privileged and is intended only for the person(s) named. Any use, distribution, copying or disclosure to any other person is strictly prohibited. If you received this transmission in error, please notify the sender by reply e-mail and then destroy the message. Opinions, conclusions, and other information in this message that do not relate to the official business of Golden Gate Capital shall be understood to be neither given nor endorsed by the company. Where applicable, any information contained in this e-mail is subject to the terms and conditions in the relevant governing agreement. <Next - Org Chart.pdf> EFTA00675453 <IMG_0430.PNG> <IMG_0431.PNG> <IMG_0432.PNG> <IMG_0433.PNG> <MG_0434.PNG> EFTA00675454